Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Ju Wei

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|July 10, 2024
Assessment of hepatitis B virus relapse in cancer patients receiving chemotherapy with prophylactic nucleos(t)ide analogues: Implications for overall mortalityChih-Wen Wang, Chung-Feng Huang, Ming-Lun Yeh, et al.
BMJ Open|May 8, 2019
Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort studyChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|September 2, 2023
Unawareness of hepatitis B infection and lack of surveillance are associated with severity of hepatocellular carcinomaKuan-I Lee, Po-Cheng Liang, Po-Yau Hsu, et al.
The Kaohsiung Journal of Medical Sciences|February 16, 2024
Third vaccine boosters and anti-S-IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinomaChih-Wen Wang, Chung-Feng Huang, Tyng-Yuan Jang, et al.
The Kaohsiung Journal of Medical Sciences|January 18, 2024
Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitisChung-Feng Huang, Po-Cheng Liang, Chih-Wen Wang, et al.
Journal of Gastroenterology and Hepatology|September 21, 2023
The interplay of metabolic dysfunction-associated fatty liver disease and viral hepatitis on liver disease severity: A large community-based study in a viral endemic areaChung-Feng Huang, Po-Cheng Liang, Pei-Chien Tsai, et al.
Microbiology Spectrum|May 17, 2022
Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk PopulationsHsin-Yun Sun, Wang-Da Liu, Chih-Wen Wang, et al.
Hepatology International|December 1, 2021
Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study)Jee-Fu Huang, Ming-Yen Hsieh, Yu-Ju Wei, et al.
Clinical and Molecular Hepatology|July 29, 2024
Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in TaiwanChung-Feng Huang, Chia-Yen Dai, Yi-Hung Lin, et al.
The Kaohsiung Journal of Medical Sciences|April 16, 2024
The efficacy of multi-disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patientsMing-Lun Yeh, Chia-Yen Dai, Chung-Feng Huang, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Liver International : Official Journal of the International Association for the Study of the Liver|July 10, 2024
Assessment of hepatitis B virus relapse in cancer patients receiving chemotherapy with prophylactic nucleos(t)ide analogues: Implications for overall mortalityChih-Wen Wang, Chung-Feng Huang, Ming-Lun Yeh, et al.
BMJ Open|May 8, 2019
Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort studyChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|September 2, 2023
Unawareness of hepatitis B infection and lack of surveillance are associated with severity of hepatocellular carcinomaKuan-I Lee, Po-Cheng Liang, Po-Yau Hsu, et al.
The Kaohsiung Journal of Medical Sciences|February 16, 2024
Third vaccine boosters and anti-S-IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinomaChih-Wen Wang, Chung-Feng Huang, Tyng-Yuan Jang, et al.
The Kaohsiung Journal of Medical Sciences|January 18, 2024
Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitisChung-Feng Huang, Po-Cheng Liang, Chih-Wen Wang, et al.
Journal of Gastroenterology and Hepatology|September 21, 2023
The interplay of metabolic dysfunction-associated fatty liver disease and viral hepatitis on liver disease severity: A large community-based study in a viral endemic areaChung-Feng Huang, Po-Cheng Liang, Pei-Chien Tsai, et al.
Microbiology Spectrum|May 17, 2022
Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk PopulationsHsin-Yun Sun, Wang-Da Liu, Chih-Wen Wang, et al.
Hepatology International|December 1, 2021
Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study)Jee-Fu Huang, Ming-Yen Hsieh, Yu-Ju Wei, et al.
Clinical and Molecular Hepatology|July 29, 2024
Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in TaiwanChung-Feng Huang, Chia-Yen Dai, Yi-Hung Lin, et al.
The Kaohsiung Journal of Medical Sciences|April 16, 2024
The efficacy of multi-disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patientsMing-Lun Yeh, Chia-Yen Dai, Chung-Feng Huang, et al.
Pageof 6